Target intelligence / Profile preview

Glutathione (Reduced) (GSH)

Target
GSH
Molecular classification
Other, Antioxidant, Endogenous metabolite, Thiol
01

Overview

Glutathione (GSH) is a vital tripeptide consisting of glutamate, cysteine, and glycine, serving as the primary low-molecular-weight thiol and antioxidant in eukaryotic cells (PubChem CID 124886). It plays a critical role in maintaining cellular redox homeostasis by scavenging reactive oxygen species and acting as a cofactor for various enzymes, including glutathione peroxidases and glutathione S-transferases (PubMed: 22549109). In clinical contexts, GSH is central to the detoxification of drugs like acetaminophen; its depletion leads to oxidative stress and cell death, particularly in the liver (StatPearls: Acetaminophen Toxicity). Conversely, many cancer cells overexpress GSH to resist the pro-oxidant effects of chemotherapy and radiation, making the GSH biosynthetic pathway a target for chemosensitization (PubMed: 28263956). Therapeutic interventions include the use of N-acetylcysteine to boost GSH levels in cases of poisoning or respiratory disease, and inhibitors like buthionine sulfoximine to deplete the pool in experimental oncology.

Other names
L-Glutathionegamma-L-Glutamyl-L-cysteinylglycineReduced glutathioneGSH
02

Mechanism of action

Glutathione acts as a nucleophilic scavenger of reactive oxygen species and electrophilic xenobiotics, often catalyzed by glutathione peroxidases and glutathione S-transferases. Therapeutic modulation involves either replenishing the GSH pool via precursors to prevent oxidative damage or depleting it to overcome drug resistance in oncology.

03

Biological functions

Signal transductionCell deathOther
04

Disease associations

CancerInflammationNeurodegenerative diseaseOther
05

Safety considerations

Oxidative stress upon depletionPotential interference with chemotherapy efficacyHepatotoxicity risk if depleted by xenobiotics
06

Interacting drugs

N-acetylcysteine

4 more in the full profile.

07

Biomarkers

GSH/GSSG ratioTotal glutathione levelsGlutathione S-transferase activity

Beyond the preview

Go deeper on Glutathione (Reduced) (GSH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutathione (Reduced) (GSH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call